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Community outbreaks of group A 
Streptococcus revealed by genome 
sequencing
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Julian Parkhill  4 & Sharon J. Peacock  4,5,6,7
The frequent occurrence of disease outbreaks in humans caused by group A Streptococcus (GAS) is an 
on-going public health threat. Conventional bacterial typing methods lack the discriminatory power to 
confidently confirm or refute outbreaks in hospital and community settings. Microbial whole genome 
sequencing (WGS) provides a potential solution to this, but, there has been limited population-based 
surveillance with accompanying sequence data. We performed retrospective genomic surveillance of 93 
clinical GAS isolates from individuals in a defined geographic region. Detailed clinical information was 
obtained for closely related clusters of isolates. Genomic sequence data was contextualised through 
comparison with international data. We identified 18 different emm genotypes within our bacterial 
population, and revealed both highly diverse and closely related isolates. This high level of diversity 
was maintained even in the context of international sequence data. We also identified two emm1 
clusters, and one emm3 cluster, of closely-related isolates that differed only by 1 to 4 single nucleotide 
polymorphisms. Analysis of clinical information identified no healthcare associated contact between 
patients, indicating cryptic community transmission. Our findings suggest that genomic surveillance of 
GAS would increase detection of transmission and highlight opportunities for intervention.
The Lancefield group A Streptococcus (GAS; Streptococcus pyogenes) is a human pathogen capable of causing a 
wide spectrum of infections, ranging from self-limiting tonsillitis and pharyngitis to severe, and potentially lethal 
necrotising fasciitis and toxic shock syndrome. Globally, an estimated 663,000 cases of invasive GAS disease occur 
per year, resulting in approximately 163,000 deaths1. Epidemiological analysis suggests that the overall incidence 
rate of invasive GAS is increasing2, and sporadic increases in global and national prevalence are often associated 
with specific emm genotypes3–9. Whole genome sequencing (WGS) data has provided explanations for some of 
these epidemiological shifts, relating these to changes in gene content. For example, the acquisition of phage 
carrying novel virulence genes has been associated with a nationwide epidemic of emm3 GAS8, and homologous 
recombination of core genomic regions has been linked with a rise in prevalence of a new emm89 GAS variant in 
the UK, Europe and North America5, 6, 10.
GAS is also associated with outbreaks of disease. Prior to WGS, probable outbreaks were defined when two 
or more cases of GAS infection, related by person or place, occurred within a year and isolates shared the same 
subtypes based on molecular typing11, 12. Conventional bacterial typing methods may fail to confirm or refute 
an outbreak, because of insufficient discrimination between strains of the same lineage. WGS has been used 
successfully to investigate a small number of putative outbreaks, confirming a single causative strain that was 
distinct from the circulating population, which were otherwise indistinguishable by standard molecular typing 
methods12–14. Where epidemiological evidence for transmission is unclear or lacking, WGS data could potentially 
provide valuable supporting evidence to assist outbreak investigations15.
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The use of WGS in routine practice will require access to contextual genome databases, to enable comparison 
of outbreak isolates with circulating lineages. This can be used to support decisions on transmission events and 
outbreaks, may provide more specific information on the abundance of variant strains and disease propensity, 
and identify cryptic disease clusters occurring in the community. There is currently a paucity of population-based 
genomic surveillance of GAS and associated sequence data. Here, we describe retrospective genomic surveillance 
of clinical GAS isolated from individuals in a circumscribed geographic region. This bacterial population con-
tained 18 different emm genotypes, and both highly diverse and closely related isolates. The presence of clusters of 
highly similar isolates with no link to healthcare is indicative of cryptic community transmission.
Results
We conducted a retrospective observational cohort study at the Cambridge University Hospitals NHS Foundation 
Trust (CUH) in the UK, and identified 93 patients with at least one GAS isolate stored between 1st January 2006 
and 31st December 2012 (Supplementary Table 1). Seventy isolates were from CUH patients, 14 from local district 
general and community hospitals (GCH), and 9 from general practice (GP). The median age of patients was 37 
years (interquartile range; 17 to 67 years), and 47/93 (51%) were male. The majority of isolates were cultured from 
blood (n = 48) or skin and soft tissue samples (n = 24). The remainder were isolated from throat swabs (n = 7), 
respiratory secretions (n = 6), bone and joint specimens (n = 1), other sites (n = 1), or unspecified sites (n = 6). 
Seven patients died as a result of the infective episode within 30 days of the study sample.
Eighteen different emm-types were derived from sequence data for the 93 isolates (Fig. 1). The most common 
were emm1 (n = 25, 27%), emm28 (n = 13, 14%) and emm89 (n = 10, 11%), consistent with previous studies from 
the UK and elsewhere17–19. Although patient numbers were small, the mortality associated with emm3 was very 
high, as 3/5 invasive emm3 isolates (60%) were associated with attributable death, compared to 2/18 (11%) emm1, 
1/6 (17%) emm12 and 1/8 (13%) emm89. Antimicrobial resistance to tetracycline, erythromycin and/or clinda-
mycin was detected in 8 isolates, and was restricted to the less common emm-types (Supplementary Table 1). 
All three emm44 isolates and the single emm58 isolate carried tetM encoding tetracycline resistance, and ermTR 
encoding erythromycin resistance and inducible clindamycin resistance20. One of six emm75 isolates carried 
ermB and tetM and was erythromycin, clindamycin and tetracycline resistant. A further three isolates (emm5, 
emm43 and emm134) were resistant to tetracycline associated with tetM.
The propensity for some strains to cause severe invasive disease has been attributed to loss-of-function muta-
tions within virulence gene regulators, in particular the two component regulatory system CovRS, which nega-
tively regulates a number of different virulence factors21–23. We extracted and compared the sequences of known 
transcriptional regulators, CovR, CovS, RocA (regulator of CovRS), RivR, Rgg1, Rgg2, Rgg3, Rgg4, and FasABCX 
(Supplementary Tables 2, 3 and 4). A single isolate (an invasive emm2) had a mutation in CovR, and 13 isolates, 
of varying emm-type, had mutations in CovS (10 invasive, 3 non-invasive isolates). Although mutations within 
CovRS have been associated with the virulence and invasive nature of GAS, particularly emm1, only two of the 18 
invasive emm1 isolates had mutations in CovS; an amino acid change of Threonine to Proline at residue 214, and 
a premature stop codon after 390/500 residues. In addition, one emm1 strain (GASAR0033) carried a duplication 
mutation of 8 bp within rocA resulting in a premature stop codon after 32 amino acids, which is predicted to 
increase virulence factor expression through loss of CovRS repression24. None of the isolates from cases who died 
carried any additional gene regulatory mutations outside of those related to the emm-type lineage. Interestingly, 
9/13 (69%) emm28 isolates carried a mutation in one of five gene regulators; CovS (2 isolates), RivR (1 isolate), 
Rgg1 (1 isolate), Rgg2 (2 isolates) and Rgg3 (3 isolates). This was a higher prevalence of regulatory gene mutations 
than other emm-types.
A maximum-likelihood tree based on 49,262 SNPs in the 1,295 conserved genes identified by pan-genome 
analysis identified clustering of isolates by emm-type (Fig. 1). Multilocus sequence type (MLST) derived from 
sequence data resolved 24 STs for the 93 isolates. Each ST contained a single emm-type, but five emm-types had 
multiple STs (Fig. 1). In each case the change in ST within an emm-type was associated with a single nucleotide 
base change within one of the seven MLST loci. We also derived emm-subtyping information (Supplementary 
Table 1) but all isolates within each emm-type were of the same emm-subtype. The exceptions were emm1, where 
the majority were emm1.0, but two isolates were emm1.52 and two isolates were emm1.6, and emm6, where the 
majority were emm6.0 but two isolates were emm6.4.
Pairwise comparison of SNPs in the core genome of isolates of the same emm-type determined a median SNP 
difference of 37 (range 0–370 SNPs), compared to 11,079 SNP differences (range 8149–13134 SNPs) between iso-
lates of different emm-types. The range of zero to 370 SNP differences between isolates within emm-types suggest 
that both identical/very closely related isolates and diverse isolates are circulating within this local population.
The presence of variable accessory genes, which are often associated with mobile prophages, were mapped to 
the phylogenetic tree (Fig. 1). The pattern of types and subtypes of variable superantigen and DNase genes were 
predominantly associated with specific emm-types, although some were variably present in specific emm-type 
clusters. For example, four of 13 emm28 strains were positive for the superantigen speA but negative for the supe-
rantigen speK; both superantigens are associated with different prophages. Three of the same four emm28 isolates 
also had a variant of the DNase spd1, commonly found on the same prophage as the superantigen speC, that 
was different from the remaining emm28 isolates, and speC and spd1 were both absent in the fourth strain. This 
suggests that epidemiological studies using detection of these variable accessory genes for isolate discrimination, 
could be enhanced by including analysis of allelic variants.
Emm1. We confirmed the presence of two clusters of closely related emm1 isolates based on core gene analy-
sis by mapping our emm1 population to an emm1 reference genome, MGAS500525 (Fig. 2). Cluster 1 contained 
three isolates, all CUH patients with invasive disease in 2010, and separated by only 1–2 SNPs. GASAR0033 
and GASAR0052 were identical by core gene phylogeny (Fig. 1), but mapping to MGAS5005 resolved a unique 
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Figure 1. Core gene maximum likelihood phylogenetic analysis of all 93 isolates. All isolates clustered by emm-type 
and there was a broad association of variable factor complement with the emm-type. The superantigens speA, speH 
and speI are highlighted in grey in emm6 strains as these are atypical variants that may not be functional. Similarly, 
all emm3 strains were found to carry a non-functional smeZ gene, as previously described16. The DNase spd1 in three 
emm28 strains is highlighted grey to indicate that it is a different variant to that found in the other emm28 strains. 
Coloured circles represent emm-type/ST. The majority of emm-types were associated with a single ST type (colours 
of emm-type identical to colour of ST). Where an additional ST was associated with an emm-type this is represent by 
a different colour ST circle. emm1 (n = 25); ST28 (red/red) or ST785 (red/pink), emm2 (n = 4); ST55, emm3 (n = 7); 
ST15 (green/green) or ST315 (green/pale green), emm4 (n = 4); ST39 (purple/purple) or ST786 (purple/pale purple) 
or ST38 (purple/paler purple), emm6 (n = 6); ST382, emm12 (n = 7); ST36, emm28 (n = 13); ST52 (blue/blue) or 
ST787 (blue/pale blue), emm44 (n = 3); ST367, emm75 (n = 6); ST150 (grey/grey) or ST788 (grey/paler grey), emm89 
(n = 10); ST101. Types represented by a single isolate comprised emm5; ST99, emm22; ST46, emm43; ST3 emm58; 
ST176, emm81; ST624, emm87; ST62, emm104; ST789, emm134; ST790. Source; Invasive (red) or non-invasive 
(black) site of isolation.
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non-synonymous SNP in GASAR0033 within a non-core gene (serine to leucine at amino acid residue 21 in 
M5005_Spy0853, short chain dehydrogenase). GASAR0033 also carried an insertion mutation in rocA, a regula-
tor of CovRS. A single nucleotide base change in the MLST gene xpt of C194T in this cluster of isolates resulted 
in the unique ST785; other emm1 strains were ST28. Two of these patients initially presented with skin and soft 
tissue infections, and the third patient with bone and joint infection; all went on to develop bacteraemia and 
multi-organ failure. Patients with skin and soft tissue infections were admitted to the intensive care unit, and one 
patient died shortly after. GASAR0033 and GASAR0052 were isolated within the same month (22 days apart), 
although both were community-acquired infections, and GASAR0047 was isolated 7 months later. We were una-
ble to identify any healthcare-related association between any of the three patients.
Cluster 2 contained two invasive isolates from CUH, GASAR0011 (isolated in 2008) and GASAR0029 (iso-
lated in 2010). They were only differentiated by a single non-synonymous mutation in rplJ in GASAR0029, but 
GASAR0011 also carried an insertion mutation in CovS of 25 bp after 1129/1503 bp truncating the protein at 
390/500 amino acids, and a deletion mutation in vfr (M5005_0693), encoding for a potential virulence factor 
regulator, truncating the protein at 80/247 amino acids. As these were isolated three years apart, it seems unlikely 
that they represent direct or recent transmission, but may reflect persistence of this variant in the population.
In addition to Cluster 1 and Cluster 2, three isolate pairs were identified within our collection that were iso-
lated 1–2 years apart and separated by only 6–7 SNPs (Fig. 2); GASAR00112 and GASAR00021, GASAR0098 and 
GASAR0065, GASAR0092 and GASAR0003. Based on a previously estimated substitution rate for emm1 GAS 
at 1.37 substitutions per core genome per year3, these isolate pairs are unlikely to represent recent transmission 
events, but may represent independent acquisitions of a lineage that is circulating in the community.
To contextualise our collection, we combined sequence data for the 25 study emm1 isolates with data for 
1210 emm1 isolates from the USA, Canada, Denmark, Finland, Norway, Iceland and Sweden, collected between 
Figure 2. Identification of closely related clusters of emm1 isolates. Phylogenetic analysis of 25 emm1 isolates 
mapped to MGAS5005 (NC_007297). Two clusters were identified that were separated by only 1–2 SNPs. Two 
sequence types were identified: ST28 (red/red) or ST785 (red/pink). All were emm-subtype 1.0 except four 
isolates, of which two were subtype 1.52 (orange) and two were 1.6 (yellow) and the isolates belonging to these 
subtypes cluster within the phylogeny. Prophages are indicated on the right (presence indicated in black). The 
majority carried typical M1 prophages 5005.1 with the superantigen speA, 5005.2 with the DNase spd3 and 
5005.3, with the DNase sda. GASAR0099 carried a prophage similar to 315.4 from the M3 strain MGAS315 
with the DNase spd4, and GASAR0112 carried a prophage similar to 2096.1 from the M12 strain MGAS2096 
with the superantigen speC and the DNase spd1. Five isolates had stop codon mutations (in black) or non-
synonymous SNP mutations (grey) in three regulatory genes; covS, rocA and rgg1/ropB. Detailed in tip labels 
are isolate name, year of isolation and site of isolation; Cambridge University Hospital (CUH), Local or tertiary 
hospitals (GCH) or GP practices (GP). Branches are coloured based on year of isolation and branch numbers 
indicate SNPs.
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2005–20133, and for 24 UK emm1 isolates from 2007–200814 (Fig. 3). Cluster 1 and Cluster 2 emm1 isolates 
remained clustered within this extended population. Our other emm1 isolates were interspersed with geograph-
ically distant isolates across the tree, indicating that the level of diversity in our local population is similar to that 
of a wider North American/European population. Of the 24 emm1 UK isolates sequenced by Turner et al.14, 15 
isolates were part of an outbreak, and were previously determined to be identical to each other but distinct from 
emm1 isolates from other parts of the UK14. Incorporation of these 15 outbreak isolates into the extensive collec-
tion here supports this finding as they are clearly distinct from other isolates (Fig. 3).
Emm3. Our local collection of seven emm3 isolates were associated with high mortality (60%). Like emm1, 
this small population consisted of diverse isolates and a cluster of closely related isolates (Fig. 4). One isolate 
belonged to a recently identified lineage (Lineage C) associated with an epidemic upsurge in invasive disease 
in the UK8. Four isolates, all obtained in 2009 but isolated one, four and almost 12 months apart from the first 
isolate, were separated by only 1–4 SNPs (Fig. 4) and two of these isolates (GASAR0006 and GASAR0062) were 
associated with a fatal outcome. They differed from their nearest relative by two non-synonymous SNPs; thre-
onine to alanine at amino acid residue 112 in rgpG, encoding a putative polysaccharide biosynthesis protein, 
and aspartic acid to asparagine at amino acid residue 588 in rpoB, a putative DNA-dependent RNA polymer-
ase subunit β. GASAR0062 also carried a SNP within the −35 transcription box of the hasA hyaluronic acid 
Figure 3. Global context of emm1 and outbreak identification. A maximum-likelihood phylogenetic tree 
was constructed using core genome SNPs (excluding prophages) identified in 1259 sequenced emm1 strains 
isolated 2005–2013 from USA (n = 381), Canada (n = 23), Denmark (n = 269), Finland (n = 204), Norway 
(n = 54), Iceland (n = 16), Sweden (n = 263)3 and the UK (n = 49)14 compared to MGAS5005. The UK isolates 
are identified by coloured branches and highlighted by coloured circles around the outside of the tree. They 
comprise 25 from the study collection (blue branches and circles), plus 9 from various locations in the UK 
(green branches and circles) and 15 emm1 outbreak isolates (red branches and circles) from a previous study14. 
Although the majority of UK isolates are dispersed across the tree, those associated with the outbreak and the 
two study local clusters (indicated by *) are clearly distinct from other emm1 isolates.
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capsule-synthesis gene promoter, which may impact on expression of the hyaluronic acid capsule. GASAR0034 
carried a synonymous SNP in pbp2a and an 11 bp deletion in CovS, truncating the protein after 221/500 amino 
acids. Detailed clinical information from all four cases indicated that three patients presented with lower respira-
tory tract infections and the fourth with pharyngitis (isolate GASAR0034). Three patients developed bacteraemia 
(isolates GASAR0006, GASAR0034, GASAR0051) and one patient had a skin and soft tissue infection. The relat-
edness of the strains determined by WGS and the supporting clinical information provides evidence that this was 
a community outbreak and that it may have extended beyond our cohort.
Emm12. A recent study into the outbreak of scarlet fever in Hong Kong identified four major clades of emm12, 
three of which were associated with scarlet fever isolates7. Our local collection of just seven emm12 contained 
isolates from each of the four major clades, suggesting that these clades are a common feature of the emm12 pop-
ulation (Supplementary Figure 1). Only two of our isolates carried the superantigen ssa which has been attributed 
to scarlet fever, both were associated with clade I but neither were associated with scarlet fever. Although there 
has been a recent increase in scarlet fever in the UK, emm12 has not yet been identified as a major contributor27.
Discussion
The limited amount of WGS data currently available for GAS means that relatively little is known about the cir-
culating populations in the community. Population-based genomic surveillance of GAS and associated sequence 
data are crucial in supporting transmission and outbreak investigations. We have identified that even within 
localised populations there can be both diverse and closely related isolates, indicating both locally circulating 
clones and the introduction of new lineages.
Analysis of the population core genome identified closely related clusters within the emm1 and emm3 gen-
otypes that differed only by 0–1 SNPs, indicative of cryptic community transmission. By mapping to a com-
pleted reference genome of the same emm-type, further differences between isolates were resolved. This suggests 
that disease clusters can be identified through pan-genome analysis without an emm-type specific reference, 
which is necessary as, although reference genomes have been proven useful, not all emm-types are represented. 
Where disease-clusters are associated with common emm-types sharing typical subtypes (MLST, emm-subtype, 
Figure 4. Diverse and closely related isolates within emm3. A maximum-likelihood phylogenetic tree was 
constructed using core genome SNPs (excluding prophages) identified in sequenced emm3 strains from 
our collection (n = 7), emm3 strains isolated 1992–2007 from Canada (n = 70)26, and emm3 strains isolated 
2001–2013 from UK and Ireland (n = 442)8, compared to the reference emm3 genome strain MGAS315. Isolates 
from our collection are highlighted in blue branches and blue circles around the outside of the tree. One of 
our isolates resided within the previously identified Lineage C (lineage highlighted grey) associated with an 
increase in invasive disease in the UK8. This strain, like the majority of others within this lineage, carries the 
superantigen speC and the DNase spd1 but has lost the superantigen ssa. An expanded region of the main tree is 
indicated on the right hand side and highlights four 2009 isolates that are separated from each other by only 1–4 
SNPs. Branch labels represent number of SNPs.
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resistance genes), WGS can provide irrefutable evidence of relatedness and identify any unique features that 
could underpin a specific disease phenotype. In our study, we did not have sufficient numbers to directly link 
variant isolates or transcriptional regulatory gene mutations with specific clinical markers or disease out-
comes. Unusually, however, our emm28 isolates did show a higher level of regulatory gene mutations than other 
emm-types, although the relevance of these mutations could not be resolved in our study. With further study 
and if WGS becomes more routine, is may be possible to tailor treatments towards the specific infection variant.
The majority of invasive disease cases were associated with emm1 and mortality was particularly high with 
emm3, making the detection and prevention of disease clusters with these emm-types critical. All patients with 
Cluster 1 emm1 isolates went on to develop severe disease, with two requiring ICU admission and one patient 
died, suggesting this variant may have propensity towards severe invasive disease. Similarly, two of the four 
closely-related cluster emm3 isolates were associated with mortality. These patients with emm3 presented with 
lower respiratory tract infection or pharyngitis, and went on to develop bacteraemia or, in one case, skin and soft 
tissue infection. Cluster 1 emm1 isolates carried a unique MLST and therefore may have been identified through 
routine typing. The emm3 cluster, however, lacked distinguishing conventional typing features (emm, MLST, 
variable accessory factors) suggesting that without whole genome sequencing it would not have been identified. 
The clinical reports for three of the emm3 patients indicated possible contact with other GAS patients outside of 
this cohort. Although we could not confirm this, it is possible that this cluster extended beyond the four cases 
that we identified.
There is limited data on GAS transmission and possible infection prevention strategies in the community. 
Two recent studies identified a 731–2000 fold increased risk of invasive GAS disease among household contacts 
of a GAS index case compared to the general population, indicating a potential benefit of antibiotic prophylaxis 
within households28, 29. With the rarity of index cases, the number of cases where house-hold or community 
transmission has been confirmed is very small. Real-time genomic surveillance may provide alerts to outbreak or 
transmission events and could support the introduction and assessment of community interventions.
We have demonstrated that WGS of isolates within a local population can identify cryptic community trans-
mission and disease clusters. This supports previous findings that WGS of GAS populations can identify disease 
clusters within the community as well as the spread of unusual GAS genotypes entering the population or the 
emergence of new GAS variants that may lead to disease upsurges4–6, 8, 9, 30, 31. By monitoring local bacterial pop-
ulations with WGS, informed by circulating national and international genomic data isolates, community trans-
mission could be rapidly identified and interventions put in place. It may also provide early indication of new and 
potentially harmful variants entering the population that can rapidly become epidemic.
Methods
Study Setting, Design and Participants. A retrospective observational cohort study was conducted at 
the Cambridge University Hospitals NHS Foundation Trust (CUH) in the United Kingdom (UK), a tertiary 
referral centre in the United Kingdom with 1,170 beds. We identified samples that were culture positive for GAS 
at the on-site Public Health England Clinical Microbiology and Public Health Laboratory (CMPHL) between 1st 
January 2006 and 31st December 2012. This diagnostic laboratory receives samples from three hospitals and 75 
general practice (GP) surgeries in Cambridgeshire. Isolates were cross-referenced with patient information to 
identify cases with at least one stored GAS isolate (n = 93). The first stored isolate for each patient was recovered 
from the laboratory freezer archive for sequencing. Phenotypic antibiotic susceptibility data were obtained from 
the CMPHL laboratory database. Isolates had previously been tested for susceptibility to penicillin, tetracycline, 
erythromycin, vancomycin, teicoplanin and clindamycin, using the disc diffusion method (British Society for 
Antimicrobial Chemotherapy; BSAC methods for Antimicrobial Susceptibility Testing; Version 14 January 2015). 
Inducible clindamycin resistance was detected using the D-test method.
Clinical data on all 93 cases was collected from paper and electronic patient records, and consisted of date of 
sample collection, gender, age, infection type/site and 30-day mortality. Seventy isolates were CUH patients, 14 
from local district general and community hospitals (GCH), and 9 from general practice (GP). Invasive GAS dis-
ease was defined as the isolation of GAS from a normally sterile site or from a wound in a patient with necrotizing 
fasciitis or streptococcal toxic shock syndrome32. Where we suspected clusters of related cases the healthcare 
records were retrieved and available clinical data was reviewed.
Whole genome sequencing and analysis. DNA was extracted using the QIAxtractor instrument 
(QIAgen, Hilden, Germany). DNA library preparation was conducted according to the Illumina protocol and 
sequencing was performed on an Illumina HiSeq. 2000 with 100-cycle paired-end runs. Sequence data have been 
submitted to the European Nucleotide Archive (ENA) (www.ebi.ac.uk/ena) under the accession numbers listed 
in Supplementary Table 5. Genomes were de novo assembled using Velvet33 with the pipeline and improvements 
found at https://github.com/sanger-pathogens/vr-codebase and https://github.com/sanger-pathogens/assembly_
improvement (assembly statistics in Supplementary Table 5). Genome assemblies were annotated using Prokka 
and a pan-genome estimated using Roary34. A maximum-likelihood tree was created based on 49,262 single 
nucleotide polymorphisms (SNPs) in the 1,295 conserved genes (present in 100% of isolates with greater than 
95% shared identity) using RAxML35, a midpoint root and 100 bootstraps. Multilocus sequence types (MLSTs) 
were identified from the sequence data using the MLST database (pubmlst.org/spyogenes) and an in-house script 
(https://github.com/sanger-pathogens/mlst_check). Emm-types were derived from sequence data and the pres-
ence of the 11 known variable chromosomal and prophage-encoded superantigen genes (speA, speC, speG-M, 
ssa, smeZ) and four prophage-encoded DNAse genes (sda, spd1, spd3, spd4) determined by BLAST analysis. The 
sequences of key virulence gene regulators (covR, covS, rocA, rgg1, rgg2, rgg3, rgg4, fasA, fasB, fasC, fasX, rivR) 
were extracted from the assembled genomes and compared to all available reference genomes to identify variant 
alleles. Within the gene regulators, some genetic variation was identified that was related to emm-type, suggesting 
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lineage specific variation and not spontaneous non-functional mutants. We therefore only defined alleles as 
potential non-functional mutant variants when non-synonymous SNPs occurred in addition to emm-type line-
age specific variations.
To provide genetic context, sequence data for 1210 emm1 isolates from USA/Canada/Europe3 and 24 UK 
emm1 isolates14 were downloaded from the ENA and combined with the 25 study emm1 genomes and mapped 
to the genome of GAS emm1 strain MGAS5005 (ENA accession number NC_007297). Sequence data for 442 
emm3 GAS isolates from the UK and Ireland8 and 70 Canadian emm3 isolates26 were downloaded from ENA and 
mapped with the 7 study emm3 genomes to emm3 strain MGAS315 (ENA accession number NC_004070). 132 
emm12 isolates from Hong Kong collected between 2005–20117 were downloaded from the ENA and combined 
with the 7 study emm12 isolates and mapped to emm12 strain HKU16 (ENA accession number AFRY01000001). 
All mapping was performed using SMALT (http://www.sanger.ac.uk/resources/software/smalt/), and SNPs in the 
core genome (excluding prophages) were used to construct a maximum-likelihood tree using RAxML35.
Ethics approval. The study was approved by the National Research Ethics Service (ref: 12/EE/0439) the 
Cambridge University Hospitals NHS Foundation Trust Research and Development Department (ref: A092428) 
and we performed the study in accordance with the guidelines and regulations.
Data availability. Sequence data have been submitted to the European Nucleotide Archive (ENA) (www.ebi.
ac.uk/ena) under the accession numbers listed in Supplementary Table 5.
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